Nom du produit:(3R)-3-(Cyclopropylamino)-1-piperidinecarboxamide

IUPAC Name:(3R)-3-(cyclopropylamino)piperidine-1-carboxamide

CAS:2837996-46-8
Formule moléculaire:C9H17N3O
Pureté:95%+
Numéro de catalogue:CM1075321
Poids moléculaire:183.26

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2837996-46-8
Formule moléculaire:C9H17N3O
Point de fusion:-
Code SMILES:N([C@H]1CN(C(N)=O)CCC1)C2CC2
Densité:
Numéro de catalogue:CM1075321
Poids moléculaire:183.26
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

JNT-517
Jnana Therapeutics announced positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with phenylketonuria (PKU). JNT-517, a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19, is being evaluated as a potential first-in-class oral treatment for PKU across all ages and genotypes. Based on these positive mid-term results, Jnana has adjusted its phase 1b clinical trial design to support the critical phase 3 clinical trial of JNT-517 starting in the first half of 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.